536 related articles for article (PubMed ID: 6430642)
41. Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilization.
Mashiach S; Dor J; Goldenberg M; Shalev J; Levran D; Rudak E; Nebel L; Goldman B; Blankstein J; Ben-Rafael Z
Gynecol Endocrinol; 1989 Jun; 3(2):107-15. PubMed ID: 2816477
[TBL] [Abstract][Full Text] [Related]
42. Further studies on pituitary and ovarian function in women receiving hormonal contraception.
Cohen BL; Katz M
Contraception; 1981 Aug; 24(2):159-72. PubMed ID: 6794980
[TBL] [Abstract][Full Text] [Related]
43. The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation.
Souka AR; el Sokkary H; Kamel M; Hassan M
Contraception; 1986 Apr; 33(4):365-71. PubMed ID: 3731776
[TBL] [Abstract][Full Text] [Related]
44. Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
van der Does J; Exalto N; Dieben T; Bennink HC
Contraception; 1995 Dec; 52(6):357-61. PubMed ID: 8749599
[TBL] [Abstract][Full Text] [Related]
45. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
[TBL] [Abstract][Full Text] [Related]
46. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
47. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D; Smith S; Zacur H
Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
[TBL] [Abstract][Full Text] [Related]
48. Up-regulatory effect of triphasic oral contraceptive on platelet 3H-imipramine binding sites.
Weizman A; Morgenstern H; Kaplan B; Amiri Z; Tyano S; Ovadia Y; Rehavi M
Psychiatry Res; 1988 Jan; 23(1):23-9. PubMed ID: 2834763
[TBL] [Abstract][Full Text] [Related]
49. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
Croxatto HB; Diaz S; Pavez M; Miranda P; Brandeis A
Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
[TBL] [Abstract][Full Text] [Related]
50. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
Alvarez F; Brache V; Tejada AS; Faúndes A
Contraception; 1986 Feb; 33(2):111-9. PubMed ID: 3084166
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.
Spona J; Feichtinger W; Kindermann C; Wünsch C; Brill K
Contraception; 1996 Nov; 54(5):299-304. PubMed ID: 8934064
[TBL] [Abstract][Full Text] [Related]
52. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
Aden U; Jung-Hoffmann C; Kuhl H
Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261
[TBL] [Abstract][Full Text] [Related]
53. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Prasad RN; Liew D; Ratnam SS
Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
[TBL] [Abstract][Full Text] [Related]
54. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users.
van der Spuy ZM; Sohnius U; Pienaar CA; Schall R
Contraception; 1990 Dec; 42(6):597-609. PubMed ID: 2128047
[TBL] [Abstract][Full Text] [Related]
55. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
Ryu K; Yu HK; Kwak HM; Hong SS
Contraception; 1983 Mar; 27(3):299-310. PubMed ID: 6406140
[TBL] [Abstract][Full Text] [Related]
56. Pulsatile luteinizing hormone secretion during the first and the fourth cycle on two different oral contraceptives containing gestodene.
Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
Acta Endocrinol (Copenh); 1993 Sep; 129(3):229-36. PubMed ID: 8212988
[TBL] [Abstract][Full Text] [Related]
57. The effects of ampicillin on oral contraceptive steroids in women.
Back DJ; Breckenridge AM; MacIver M; Orme M; Rowe PH; Staiger C; Thomas E; Tjia J
Br J Clin Pharmacol; 1982 Jul; 14(1):43-8. PubMed ID: 6809025
[TBL] [Abstract][Full Text] [Related]
58. Metabolic effects of combined oral contraceptive preparations.
Singh BM; Nutter SA; Nattrass M
Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
[TBL] [Abstract][Full Text] [Related]
59. The lack of interaction between temafloxacin and combined oral contraceptive steroids.
Back DJ; Tjia J; Martin C; Millar E; Mant T; Morrison P; Orme M
Contraception; 1991 Apr; 43(4):317-23. PubMed ID: 1906791
[TBL] [Abstract][Full Text] [Related]
60. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
